Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Cannabis 'cuts pain' from damaged nerves

  • Comment

Smoking cannabis from a pipe can significantly reduce chronic pain in patients with damaged nerves, a study has shown.

Smoking the drug also lessened anxiety and depression, according to the team of Canadian scientists who conducted a trial to test inhaled cannabis in 21 patients with chronic neuropathic pain caused by traumatic injury or surgery.

The researchers used herbal cannabis, or “grass”, at four potency levels. Patients aged 25 to 77 were asked to smoke 25 milligrams of the drug from a pipe three times a day.

The highest-potency cannabis, containing 9.4% of the active ingredient THC, was found to reduce pain, decreased anxiety and depression, and aided sleep.

Lead researcher Dr Mark Ware, director of clinical research at the Alan Edwards Pain Management Unit at the McGill University Health Centre, said: “We found that 25mg herbal cannabis with 9.4% THC, administered as a single smoked inhalation three times daily for five days, significantly reduces average pain intensity compared with a 0% THC cannabis placebo in adult subjects with chronic post-traumatic/post-surgical neuropathic pain.”

No serious adverse effects occurred during the trial. All the patients taking active cannabis reported one occasion of feeling “high” and euphoric, and some complained of headaches, dry eyes, a burning sensation, dizziness, numbness and coughs.

No significant changes in vital signs, heart rate or kidney function were recorded.

The findings, reported in the Canadian Medical Association Journal, are believed to be the first from a clinical trial of smoked cannabis.

The authors recommended more studies with higher potencies of THC, longer follow-up periods, and flexible dosing.Long-term safety studies of smoked cannabis for medical purposes were also needed, said the researchers.

 

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.